Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The study is to observe the efficacy and toxicity of demethylating drug decitabine and
cisplatin induced chemotherapy for 3 cycles followed by concurrent chemoradiotherapy in the
treatment of regionally advanced nasopharyngeal carcinoma,followed up for 2 years, observing
the 2-year survival rate and variation of degrees of methylation before and after
treatment,providing clinical basis for the clinical study of stage II-III.